Answer
Patients experiencing infusion-related reactions to trastuzumab emtansine should not drive or use machines until symptoms abate.
Sources for this answer
- Kadcyla 100 mg and 160 mg Powder for Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 20Document updated
Sources checked